(Q68553836)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

title

Salvage chemotherapy for non Hodgkin's lymphoma of unfavourable histology with a combination of CCNU and vinblastine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference

1 reference

Palmieri G

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

Lauria R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

Caponigro F

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

Pagliarulo C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

Montesarchio V

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

Nuzzo F

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

Gridelli C

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

Bianco AR

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

publication date

1 July 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

published in

Hematological Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

page(s)

179-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

Results of MIME salvage regimen for recurrent or refractory lymphoma

25 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080402

7 January 2021

High-dose cyclophosphamide in the treatment of refractory lymphomas and solid tumor malignancies

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080402

7 January 2021

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080402

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080402

7 January 2021

Autologous bone marrow rescue is unnecessary after very-high-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080402

7 January 2021

Identifiers

DOI

10.1002/HON.2900080402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2210686%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference